mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |